Paper42381925
Microbiome differential abundance methodologies to detect relevant taxa associated with chemotherapy toxicity rate in colorectal cancer.
Martín-De Arribas E and 8 others. Bioinform Adv, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Microbiome differential abundance methodologies to detect relevant taxa associated with chemotherapy toxicity rate in colorectal cancer. Papers, record 42381925. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42381925
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Microbiome differential abundance methodologies to detect relevant taxa associated with chemotherapy toxicity rate in colorectal cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19897823 | Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. | Behav Res Methods | 2009 | https://conductscience.org/library/papers/19897823 | PubMed |
| 2 | 41395614 | Gut microbiome alterations and their clinical and biological implications in ovarian cancer: a systematic review. | Front Oncol | 2025 | https://conductscience.org/library/papers/41395614 | PubMed |
| 3 | 34325496 | Sample size determination and power analysis using the G*Power software. | J Educ Eval Health Prof | 2021 | https://conductscience.org/library/papers/34325496 | PubMed |
| 4 | 37179402 | Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37179402 | PubMed |
| 5 | 3322052 | The proof and measurement of association between two things. By C. Spearman, 1904. | Am J Psychol | 1987 | https://conductscience.org/library/papers/3322052 | PubMed |
| 6 | 29181446 | Discrete False-Discovery Rate Improves Identification of Differentially Abundant Microbes. | mSystems | 2017 | https://conductscience.org/library/papers/29181446 | PubMed |
| 7 | 35986393 | A comprehensive evaluation of microbial differential abundance analysis methods: current status and potential solutions. | Microbiome | 2022 | https://conductscience.org/library/papers/35986393 | PubMed |
| 8 | 31695033 | Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis. | Nat Commun | 2019 | https://conductscience.org/library/papers/31695033 | PubMed |
| 9 | 34034646 | Comparison study of differential abundance testing methods using two large Parkinson disease gut microbiome datasets derived from 16S amplicon sequencing. | BMC Bioinformatics | 2021 | https://conductscience.org/library/papers/34034646 | PubMed |
| 10 | 35421994 | LinDA: linear models for differential abundance analysis of microbiome compositional data. | Genome Biol | 2022 | https://conductscience.org/library/papers/35421994 | PubMed |
| 11 | 21702898 | Metagenomic biomarker discovery and explanation. | Genome Biol | 2011 | https://conductscience.org/library/papers/21702898 | PubMed |
| 12 | 24699258 | Waste not, want not: why rarefying microbiome data is inadmissible. | PLoS Comput Biol | 2014 | https://conductscience.org/library/papers/24699258 | PubMed |
| 13 | 36927206 | Intestinal bacteria and colorectal cancer: etiology and treatment. | Gut Microbes | 2023 | https://conductscience.org/library/papers/36927206 | PubMed |
| 14 | 34262150 | The gut microbiome: what the oncologist ought to know. | Br J Cancer | 2021 | https://conductscience.org/library/papers/34262150 | PubMed |
| 15 | 23828941 | The long-term stability of the human gut microbiota. | Science | 2013 | https://conductscience.org/library/papers/23828941 | PubMed |
| 16 | 38747616 | Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-institutional Prospective Cohort Evaluation. | Cancer Res Commun | 2024 | https://conductscience.org/library/papers/38747616 | PubMed |
| 17 | 24910773 | Unifying the analysis of high-throughput sequencing datasets: characterizing RNA-seq, 16S rRNA gene sequencing and selective growth experiments by compositional data analysis. | Microbiome | 2014 | https://conductscience.org/library/papers/24910773 | PubMed |
| 18 | 35039521 | Microbiome differential abundance methods produce different results across 38 datasets. | Nat Commun | 2022 | https://conductscience.org/library/papers/35039521 | PubMed |
| 19 | 40391895 | Microbial vitamin biosynthesis links gut microbiota dynamics to chemotherapy toxicity. | mBio | 2025 | https://conductscience.org/library/papers/40391895 | PubMed |
| 20 | 36765824 | Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36765824 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42381925
GET https://conductscience.org/api/papers/v1/42381925/references?page=2